Meet our team
Andreas has experience from both clinical practice and research in health care. He is the founder of a medical simulation and training center for minimal invasive surgery at Karolinska University Hospital. Since 2004, Andreas has worked in financial markets, focusing on stock trading and was the founder and CEO of the electronic stock broker Spring Securities. He is a trained physicist and physiotherapist.
Gunnar Lundgren has more than 20 years of experience working with investment advice in the banking and insurance industry. He most recently comes from Handelsbanken Liv where his latest position was Senior Financial Advisor, Business Development. Prior to that, he was Head of Sales for Private Banking Asia in Singapore for four years. Gunnar has previously worked as Head of Sales/Area Manager at the insurance company Handelsbanken Liv and as Head of Marketing & Sales at Handelsbanken Finance.
Johan has worked for 20 years in finance and has thorough experience in the field of share issues and capital raising. He was previously Deputy CEO of Aqurat Fondkommission, Head of Issuer Services at Aktieinvest FK and before that at Carnegie Investment Bank. As a Nasdaq Certified Adviser, Johan guided companies in the listing process and provided advice on the companies’ communication to the stock market.
Teodora soon attains a Ph.D. in medical science from Karolinska Institutet (KI), where she has conducted cancer and new cancer treatment research studies. Previously she studied biomedicine at KI, she has been an active member of Swedish Young Shareholders' Association and studied medical innovation and entrepreneurship through Stockholm School of Entrepreneurship (SSES).
Joseph is an investor in life sciences and is a PhD student in genetic engineering and bioinformatics, working at SciLifeLab in Stockholm. He previously studied medical biotechnology at KTH Royal Institute of Technology in Stockholm and economics at Stockholm University.
Andrea's most recent position was at AstraZeneca. Previously, she has worked with marketing strategies at Novozymes and with business development at Clinical Microbiomics. She studied biotechnology at the Technical University of Denmark and business administration and bio-entrepreneurship at Copenhagen Business School.
Malin previously held the position of CFO at the electronic stock broker Spring Securities where she developed the company’s finance and risk functions. Prior to this, Malin worked as an analyst at the corporate finance company Billström & Mucher, as a translator at PwC and as an accounting assistant at H&M. Malin studied accounting and financial management at the Stockholm School of Economics.
Back Office Manager
Christina has many years of experience in regulatory compliance and risk management and held most recently the position of Operational Compliance Officer at Aon. Prior to that, she was the Claims Manager for Aon Sweden’s health claims department responsible for claims management, insurance, and claims administration.
Charlotte Smirnova Lindblom
Marketing & Communication Manager
Charlotte has 20+ years of experience in language and communication from among others Norstedts Ordbok, BabyBjörn, and most recently Framfot Company Training. At BabyBjörn, she was for many years Senior Linguistic Manager and later Managing Editor for the company's multilingual online magazine. As Digital Content Creator at Framfot, she managed the company's content marketing.
External board members and advisors
Chairman of the Board
Erik is COO of KRY and an Advisory Board Member at Wistrand Advokatbyrå. He has many years of experience in media and IT management and was previously Head of Change Office at Schibsted Media Group, COO of Schibsted Sweden and a Board Member of, among others, Schibsted Growth, Svenska Dagbladet, Aftonbladet and Hitta.se. Erik holds a master's degree from Stockholm School of Economics.
Gunnar is a surgeon and earned his Ph.D. at Karolinska Institutet in Stockholm. He has 30 years of clinical and strategic experience in senior management positions in healthcare. He is the Chief Medical Officer for GHP Specialty Care, a Board Member of EAES, and a researcher at Karolinska Institutet. Formerly, Gunnar was Head of Business Development at Praktikertjänst, CEO of Sollentuna Specialistklinik, and Head of Department at Sabbatsberg Hospital.
Bengt is a pharmacist and began his career in the pharmaceutical industry in 1978 at Astra. During the 1980s, Bengt was the Nordic General Manager of Baxter Healthcare. Since 1990, he has been an active investor and Board Member of a variety of life science companies. Bengt is the chairman of the board of Linc AB, an investment company with holdings in, among others, Medivir, Calliditas Therapeutics, and Sedana Medical.
Thomas is an active business angel and investor in growth companies. He has a broad range of experience in the IT and finance sectors and was previously Head of Sales and Business Development at Aktietorget (now Spotlight) and Burgundy Oslo Börs, the founder of Exnet Transaction Services, Product Manager at Itiviti and Sales Manager at Sungard Financial Systems.
Sciety is an investment syndicate striving to make innovations reach their full potential. Our experienced and committed team also provides market analyses and investor relation services to companies within our segments.
Sciety AB (556990-3692) is regulated by Finansinspektionen and is a member of the Swedish Private Equity & Venture Capital Association (SVCA) and SwedenBIO (trade association for life science industry).
This is what our clients say
"I have invested in unlisted companies during a number of years. What I really appreciate with Sciety is that they very carefully consider my interests – from the first meeting to the completed investment. With Sciety, I feel confident that the relevant documents are in place and that I receive a very good decision-making basis for my investments."
Martin Öhrn, Private investor
"I can highly recommend Sciety. Their investor syndicate is very valuable to the high tech companies managed by SU Holding. We are, of course, also very pleased with the high return we received on our investment in EMPE Diagnostics."
Mona Wilcke, CEO of SU Holding
"The Sciety team is professional with a rare blend of expertise in life science, finance and entrepreneurship. Their network of investors is of great value for high tech companies such as Attana. Thanks to our fundraising with Sciety, we have also gained new, valuable competence in our board."
Teodor Aastrup, CEO of Attana
“Sciety offers a professional and structured way to access financing at an early stage. Life science projects are often difficult to analyse; therefore, Sciety’s focus on this segment is positive for both companies seeking financing and for investors looking for new investment possibilities.”
Fredrik Sjövall, CEO of Inhalation Sciences
"Sciety maintains an efficient process and provides solid experience in raising capital. We have received several competent and financially strong shareholders and for that we are very grateful."
Mats Hilmersson, CEO of Cavis Technologies
Why Life Science?
With challenges such as an aging population, life style and chronic illnesses, there is a major requirement for new forms of treatment and preventive measures. The industry is also characterised by an increasing degree of client awareness and cost efficiency. Today, we see new, interesting areas such as AI, precision medicines and remote healthcare growing very rapidly, creating the need of improved diagnostics, medical technology, digital platforms and new business models.
There are many prominent companies, researchers and clinics in Sweden developing today’s, and the future’s, healthcare and treatment solutions. We also see an increasing number of purchasers of new services and products –from healthcare providers and pharmacists to pharma and insurance companies, and from employers. Sciety sees a major investment potential in companies offering, new, effective solutions to healthcare providers in order that they can, in their turn, contribute to improved health for more people.